Skip to the main content

Professional paper

https://doi.org/10.20471/acc.2019.58.s2.08

Radiotherapy of Prostate Cancer: Primary Radiotherapy and Radiotherapy in Disease Relapse

Katarina Antunac orcid id orcid.org/0000-0002-8356-9897 ; University Hospital for Tumors, Sestre milosrdnice University Hospital Center


Full text: english pdf 366 Kb

page 46-59

downloads: 372

cite


Abstract

Radiotherapy presents one of the essential modes of treatment in patients with prostate cancer at almost any stage of the disease. It can be delivered as external beam radiotherapy, as brachytherapy or two methods combined. Higher radiation doses are proven to be more effective than low doses and moderate hypofractionation with doses up to 3.4 Gy per fraction is proven equivalent to standard fractionation using 1.8- 2 Gy per fraction. Stereotactic body radiotherapy (SBRT) with doses from 3.4 to 7.25 Gy per fraction presents valuable option in certain subgroups of patients. In case of local regional disease relapse, radiotherapy is used in curative setting.

Keywords

prostate cancer; radiotherapy; brachytherapy; hypofractionation; stereotactic body radiotherapy; salvage radiotherapy

Hrčak ID:

234264

URI

https://hrcak.srce.hr/234264

Publication date:

1.11.2019.

Article data in other languages: croatian

Visits: 1.915 *